相关实验视频

Updated: Jul 16, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

FOXM1,MEK和CDK4/6:恶性外围神经膜瘤治疗的新标

Ellen Voigt^1,2,3, Dawn E Quelle^1,2,3,4,5

¹Cancer Biology Graduate Program, University of Iowa, Iowa City, IA 52242, USA.

International journal of molecular sciences

|September 9, 2023

概括

恶性外周神经膜瘤 (MPNSTs) 是致命的癌症. 本综述探讨了瘤转录因子FOXM1在MPNST发育中的作用,并建议FOXM1,MEK和CDK4/6作为潜在的治疗点.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

恶性外周神经膜瘤 (MPNSTs) 是具有有限治疗选择的侵袭性瘤.
大约50%的MPNST发生在患有神经纤维素瘤I型 (NF1) 的个体中,通常从良性状神经纤维瘤 (PNF) 进展.
了解PNF-MPNST转换的分子驱动因素对于开发向疗法至关重要.

研究的目的:

本综述研究了瘤转录因子FOXM1在MPNSTs中的作用.
它研究了FOXM1在MPNST中的关键信号通路的潜在调节和相互作用,包括MEK和CDK4/6.6.
这项研究旨在确定MPNST治疗的新型治疗点.

主要方法:

文献综述侧重于FOXM1在MPNST和其他癌症中的功能.
对患者MPNSTs的FOXM1表达现象现有数据的分析.
讨论FOXM1,MEK和CDK4/6通路之间的潜在调节相互作用.

主要成果:

在患者的MPNST中观察到FOXM1表达的升高,与生存率较差相关.
福克斯M1是已知的其他癌症的瘤基因,但其在MPNST中的特定作用在很大程度上尚未被探索.
讨论了FOXM1与MPNST中常见改变的MEK和CDK4/6激酶通路之间的潜在联系.

结论:

福克斯M1代表了一个有希望的,但尚未研究的,MPNSTs的治疗点.
针对FOXM1,结合MEK和CDK4/6通路,可能为MPNST患者提供新的治疗策略.
需要进一步研究FOXM1在MPNST病原体的精确机制.

关键词:

在CDK4/6中使用.在FOXM1中,我们可以看到FOXM1.这就是MEK MEK.MPNST MPNST 的意思是肉瘤肉瘤是一种肉瘤.有针对性的治疗.

更多相关视频

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...